StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical profit margin

Profit margin (net margin) is net income as a percentage of revenue.

VitaSpring Biomedical's profit margin for the twelve months ending Oct 31, 2022 was 11.7%. For fiscal 2022 it was 16.2%, against 171.4% the year before. The highest annual figure on record is 171.4% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Jan 31, 202216.2%−155.2
FY2021Jan 31, 2021171.4%+125.7
FY2020Jan 31, 202045.7%+176.1
FY2019Jan 31, 2019-130.4%−91.1
FY2018Jan 31, 2018-39.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2023CQ1 2022Apr 30, 202218.6%−25.6
Q4 FY2022CQ4 2021Jan 31, 202216.8%−186.7
Q3 FY2022CQ3 2021Oct 31, 2021374.2%−152.6
Q2 FY2022CQ2 2021Jul 31, 2021-18.0%+99.9
Q1 FY2022CQ1 2021Apr 30, 202144.1%+132.8
Q4 FY2021CQ4 2020Jan 31, 2021203.5%+17606.1
Q4 FY2020CQ4 2019Jan 31, 2020526.9%+1125.3
Q1 FY2020CQ1 2019Apr 30, 2019-117.9%−157.9
Q4 FY2019CQ4 2018Jan 31, 2019-88.7%+147.1
Q3 FY2019CQ3 2018Oct 31, 2018-17402.7%−17396.5
Q2 FY2019CQ2 2018Jul 31, 2018-598.4%−575.1
Q1 FY2019CQ1 2018Apr 30, 201840.0%+58.0
Q4 FY2018CQ4 2017Jan 31, 2018-235.8%–
Q3 FY2018CQ3 2017Oct 31, 2017-6.2%–
Q2 FY2018CQ2 2017Jul 31, 2017-23.4%–
Q1 FY2018CQ1 2017Apr 30, 2017-18.0%–

More VitaSpring Biomedical figures

See a number that looks wrong?